APA

Angell R., Aston N. M., Bamborough P., Buckton J. B., Cockerill S., deBoeck S. J., Edwards C. D., Holmes D. S., Jones K. L., Laine D. I., Patel S., Smee P. A., Smith K. J., Somers D. O. & Walker A. L. (20080822). Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity. : Bioorganic & medicinal chemistry letters.

Chicago

Angell Richard, Aston Nicola M, Bamborough Paul, Buckton Jacky B, Cockerill Stuart, deBoeck Suzanne J, Edwards Chris D, Holmes Duncan S, Jones Katherine L, Laine Dramane I, Patel Shila, Smee Penny A, Smith Kathryn J, Somers Don O and Walker Ann L. 20080822. Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity. : Bioorganic & medicinal chemistry letters.

Harvard

Angell R., Aston N. M., Bamborough P., Buckton J. B., Cockerill S., deBoeck S. J., Edwards C. D., Holmes D. S., Jones K. L., Laine D. I., Patel S., Smee P. A., Smith K. J., Somers D. O. and Walker A. L. (20080822). Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity. : Bioorganic & medicinal chemistry letters.

MLA

Angell Richard, Aston Nicola M, Bamborough Paul, Buckton Jacky B, Cockerill Stuart, deBoeck Suzanne J, Edwards Chris D, Holmes Duncan S, Jones Katherine L, Laine Dramane I, Patel Shila, Smee Penny A, Smith Kathryn J, Somers Don O and Walker Ann L. Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity. : Bioorganic & medicinal chemistry letters. 20080822.